|
|
 |
|
Viewing report
|
|
|
|
Bio/Pharma R&D Statistical Sourcebook 2010/2011
Cambridge Healthtech Institute, Aug 2010, Pages: 320
The Bio/Pharmaceutical R&D Statistical Sourcebook 2010/2011 is the leading resource for statistics, trends, and proprietary market intelligence and analysis on the biopharmaceutical industry. Supported by thousands of graphs, illustrations, and analysis, the Sourcebook provides the latest intelligence on every aspect of biopharmaceutical development, from product discovery, to R&D performance and productivity, to time-to-market trends.
With key analysis and contributions from leading consultancies and experts, the sourcebook provides real-world data and analysis, including:
- New proprietary analysis on US clinical trial starts, segmented by therapeutic category, as well as overall active clinical trials
- Emerging data on worldwide and company-specific R&D pipelines and product launch trend
- An all-new and comprehensive analysis of clinical research off-shoring revealing which pharma companies are now locating their new clinical trials overseas
- New analysis on emerging trends in pharma and biotech licensing deals and other partnerships critical to industry's efforts
- Drug approval statistics compiled from FDA, EMEA, and other regulatory agencies
- New global R&D spending trends and other international R&D data from key markets
- International statistics on drug development output
- And much more!
Plus, NEW in the 2010/2011 edition:
- Analyses on the likely impact of theranostics
- Analyses on personalized medicine and its impact on the biopharma market
- Forecasting models on biopharma sales, R&D spending, and other meaningful industry metrics
The Bio/Pharmaceutical R&D Statistical Sourcebook 2010/2011 is a must-have resource for the drug development industry. It is an invaluable resource for executives and managers working in the pharma and biotech industries. The Sourcebook puts real-world data sets at your fingertips for presentations, reports, business development efforts, strategic meetings, and critical decision-making analyses.
The 2010/2011 edition will once again be offered in electronic format for individual users, small groups, business units, or for company-wide access.
To view the reports full table of contents, please see the samples provided.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011
Chinese Biopharmaceutical Industry: Current State and Future
Clinical Operations: Benchmarking Per-Patient Trial Costs, Staffing and Adaptive Design
Biotechnology in India - An Indian Market Report
Biomarkers, Tests and Trends for Drug R&D
Industry Insight - Indian Biopharma
Success with Biobetters: Young Biobetters Companies and Pipelines
Biotech Investment and Business Trends: Weathering the Economic Storm
Biotech Investment and Business Trends: Surviving the Long Road to Market
The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles
|
|
|
|
